Getting to Know Semaglutide and Other GLP-1–Based Medications
Richard Skiba
This audiobook is narrated by a digital voice.
Semaglutide has changed countless lives—but what is it, how does it work, and what should you really expect?
This book takes you inside the science and the real-world journey of GLP-1 therapy, offering...
Location:
United States
Description:
This audiobook is narrated by a digital voice. Semaglutide has changed countless lives—but what is it, how does it work, and what should you really expect? This book takes you inside the science and the real-world journey of GLP-1 therapy, offering clear explanations, practical strategies, and honest guidance for anyone considering semaglutide for weight loss, diabetes, or improved metabolic health. Learn how the medication works, what the research shows, how to manage side effects, how to set realistic goals, and how to build the habits that make results sustainable. Beyond the clinical facts, this book explores the social impact of semaglutide—stigma, media hype, online misinformation, access issues, and the ethics of cosmetic use. Whether you are a patient, caregiver, or healthcare professional, this is your roadmap to safe, informed, and empowering semaglutide treatment. Duration - 18h 47m. Author - Richard Skiba. Narrator - Digital Voice Cole G. Published Date - Saturday, 11 January 2025. Copyright - © 2025 Richard Skiba ©.
Language:
English
Getting to Know Semaglutide and Other GLP-1–Based Medications
Duration:00:00:03
Introduction
Duration:00:02:51
Chapter 1: What Is Semaglutide?
Duration:00:01:41
Overview of Semaglutide as A GLP-1 Receptor Agonist
Duration:00:29:59
The History Of GLP-1 Discovery and Diabetes/Obesity Treatments
Duration:00:14:14
Why Semaglutide Stands Out Among GLP-1 Medications
Duration:00:06:02
Brand Names: Ozempic, Wegovy, Rybelsus
Duration:00:04:09
Oral Vs Injectable Forms
Duration:00:05:14
How Widespread Its Use Has Become in Medicine and Media
Duration:00:04:18
Chapter 2: How Semaglutide Works in the Body
Duration:00:03:14
Physiology of GLP-1 and the Incretin System
Duration:00:09:24
Mechanism of Action
Duration:00:13:48
Differences Between Semaglutide and Older GLP-1 Agonists
Duration:00:07:39
Why Low-Dose Sustained Action Works
Duration:00:05:29
Pathways
Duration:00:05:02
Chapter 3: Approved Uses and Medical Indications
Duration:00:02:36
Treatment of Type 2 Diabetes (T2DM)
Duration:00:06:39
Weight Management in Obesity and Overweight with Comorbidities
Duration:00:07:26
Cardiovascular Risk Reduction
Duration:00:03:59
Emerging Evidence: NAFLD/NASH, PCOS, Prediabetes
Duration:00:18:00
Differences Between Regulatory Approvals In US, Australia, EU, UK, Asia
Duration:00:03:55
Limitations and Contraindications
Duration:00:14:26
Chapter 4: Forms, Dosing, and Administration
Duration:00:02:21
Overview of Injectable (Subcutaneous) Formulations
Duration:00:07:33
Overview of Oral Semaglutide (Rybelsus)
Duration:00:08:50
Dose-Escalation Schedules and Rationale
Duration:00:06:55
Storage, Handling, Pen Devices, Injection Technique
Duration:00:13:30
Timing Considerations, Missed Doses, Switching Formulations
Duration:00:11:52
Example Charts/Tables for Dose-Titration
Duration:00:04:18
Chapter 5: Clinical Benefits and Expected Outcomes
Duration:00:02:01
Glycaemic Control and Hba1c Reduction
Duration:00:11:40
Weight-Loss Outcomes, Timeframes, and Realistic Expectations
Duration:00:12:26
Cardiovascular Outcome Studies (E.G., SELECT Trial)
Duration:00:29:15
Impacts on Blood Pressure, Cholesterol, Inflammation
Duration:00:06:07
Metabolic and Behavioural Changes
Duration:00:13:31
Patient Profiles: Who Responds Best?
Duration:00:05:28
Chapter 6: Side Effects, Risks, and Safety Profile
Duration:00:02:42
Common Side Effects (Nausea, Diarrhoea, Constipation, Bloating)
Duration:00:24:06
Strategies To Reduce Side Effects
Duration:00:06:18
Serious Risks: Pancreatitis, Gallbladder Issues, Hypoglycaemia (With Sulfonylureas/Insulin), Rare GI Events
Duration:00:23:36
Thyroid Tumour Concerns and Evidence
Duration:00:09:54
When to Stop the Medication
Duration:00:05:41
Safety In Pregnancy, Breastfeeding, Adolescents, Older Adults
Duration:00:11:52
Oral Contraceptive Pills and Semaglutide
Duration:00:06:49
Chapter 7: Semaglutide for Weight Loss: The Science and the Reality
Duration:00:02:08
Obesity as a Chronic Disease Vs Lifestyle Problem
Duration:00:13:19
Appetite Regulation Science (Set Point Theory, Gut–Brain Axis)
Duration:00:12:42
Why GLP-1 Medications Work When Diets Often Fail
Duration:00:04:33
Comparing Semaglutide to Bariatric Surgery Outcomes
Duration:00:30:10
Long-Term Maintenance and What Happens After Stopping
Duration:00:05:18
Myths, Misconceptions, And Media Hype
Duration:00:04:17
Chapter 8: Diet, Nutrition, and Lifestyle While Taking Semaglutide
Duration:00:01:53
Nutrition Strategies for Nausea Prevention
Duration:00:04:06
Recommended Eating Patterns (E.G., Mediterranean, High-Protein)
Duration:00:04:32
Foods That Help or Worsen Side Effects
Duration:00:03:47
Hydration, Fibre, And Bowel Health
Duration:00:04:51
Exercise Considerations and Metabolic Synergy
Duration:00:14:32
Behavioural Strategies (Mindful Eating, Hunger Cues, Portion Sizing)
Duration:00:04:49
Alcohol, Caffeine, and Substance Interactions
Duration:00:09:46
Chapter 9: Semaglutide in Diabetes Management
Duration:00:01:45
Role Relative to Metformin, SGLT2 Inhibitors, Insulin
Duration:00:19:31
How to Adjust Other Medications
Duration:00:08:10
Case Studies Showing Treatment Intensification
Duration:00:13:39
Hypoglycaemia Risk
Duration:00:04:41
Semaglutide Vs Tirzepatide in Diabetes Outcomes
Duration:00:05:24
Role in Preventing Diabetic Complications
Duration:00:04:17
Chapter 10: Pharmacology and Drug Interactions
Duration:00:02:29
Absorption, Half-Life, Metabolism, Elimination
Duration:00:19:01
Interactions
Duration:00:18:15
Special Considerations in Renal or Hepatic Impairment
Duration:00:03:23
Polypharmacy in Older Adults
Duration:00:04:17
Chapter 11: Comparison With Other GLP-1 and GIP/GLP-1 Medications
Duration:00:01:54
GLP-1 RA Class Overview
Duration:00:05:17
Semaglutide Vs Liraglutide, Dulaglutide, Exenatide, Etc.
Duration:00:06:42
Semaglutide Vs Tirzepatide (Mounjaro/Zepbound)
Duration:00:04:34
Benefits, Differences, Limitations, Cost
Duration:00:17:41
Future Pipeline: Cagrilintide, Retatrutide, Oral Multi-Incretins
Duration:00:14:20
Chapter 12: The Patient Journey: A Practical Guide
Duration:00:01:36
What to Expect in Month 1, Month 3, Month 6, And Beyond
Duration:00:04:58
Monitoring Progress (Blood Tests, Symptoms, Weight, Appetite)
Duration:00:05:26
Setting Realistic Goals
Duration:00:11:26
Managing Plateaus
Duration:00:03:55
Communicating with Your GP/Endocrinologist
Duration:00:03:47
When to Increase, Hold, or Decrease the Dose
Duration:00:03:59
Chapter 13: Ethical, Social, and Economic Issues
Duration:00:01:40
Access, Cost, and Insurance/PBS Coverage (Australia-Specific)
Duration:00:13:33
Supply Shortages and Global Demand
Duration:00:03:51
Semaglutide For Non-Medical/Cosmetic Weight Loss—Ethical Dilemmas
Duration:00:03:18
Impact on Healthcare Systems
Duration:00:07:12
Stigma, Body Image, and Public Attitudes
Duration:00:04:21
Misinformation on Social Media
Duration:00:04:49
Chapter 14: Scientific Evidence and Landmark Studies
Duration:00:01:12
Seminal Trials: STEP, SUSTAIN, PIONEER, SELECT
Duration:00:08:32
What the Data Actually Shows
Duration:00:06:35
Differences Between Diabetes-Dose Vs Obesity-Dose Outcomes
Duration:00:14:42
Place In Clinical Guidelines
Duration:00:06:32
Meta-Analyses and Real-World Evidence
Duration:00:04:36
Limitations of the Current Evidence Base
Duration:00:12:01
Chapter 15: Future Directions
Duration:00:00:04
Next-Generation Incretin Therapies
Duration:00:09:25
Semaglutide For Addiction, Alzheimer’s Disease, Fertility, PCOS—Current Research Status
Duration:00:10:42
Combination Therapies (GLP-1 + GIP + Glucagon Agonists)
Duration:00:11:11
Long-Term Sustainability of Weight Loss
Duration:00:05:30
How Personalised Medicine May Change Treatment Approaches
Duration:00:03:48
Future Regulatory Landscapes
Duration:00:04:52
References
Duration:04:40:32